Published in Int J Womens Dermatol on March 13, 2017
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol (1988) 9.51
Polycystic ovary syndrome. N Engl J Med (2005) 7.66
Clinical assessment of body hair growth in women. J Clin Endocrinol Metab (1961) 6.01
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab (2000) 3.94
Polycystic ovary syndrome. Lancet (2007) 3.62
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab (2004) 2.66
PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG (2006) 1.77
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab (2005) 1.63
The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril (2006) 1.56
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) (2002) 1.55
Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab (2006) 1.38
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2011) 1.34
Fitzpatrick skin typing: applications in dermatology. Indian J Dermatol Venereol Leprol (2009) 1.28
Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod (2013) 1.27
Skin type classification systems old and new. Dermatol Clin (2009) 1.21
Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab (2006) 1.13
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome. JAMA Dermatol (2016) 1.10
Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet (2012) 1.08
Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest (2010) 1.05
Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril (2011) 1.01
Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up. Hum Reprod (2010) 0.99
Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod (2012) 0.97
Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids (2013) 0.93
Interobserver variability of modified Ferriman-Gallwey hirsutism score in a Turkish population. Arch Gynecol Obstet (2008) 0.92
[Clinical evaluation of body hair in healthy women]. Rev Med Chil (1995) 0.86
Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome. Int J Gynaecol Obstet (2009) 0.86
Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study. Fertil Steril (2011) 0.86
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin Endocrinol (Oxf) (2010) 0.85
Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome. Fertil Steril (2014) 0.83
Polycystic ovary syndrome and its relevance to women from south Asia. Ceylon Med J (2002) 0.81
[Investigation of body hair assessment of Chinese women in Shandong region and its preliminary application in polycystic ovary syndrome patients]. Zhonghua Fu Chan Ke Za Zhi (2007) 0.81
Clinical diagnosis of hirsutism in Thai women. J Med Assoc Thai (2004) 0.81
The hirsutism scoring system should be population specific. Fertil Steril (2005) 0.79
Evidence-based approach to cutaneous hyperandrogenism in women. J Am Acad Dermatol (2015) 0.78
Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study. Fertil Steril (2013) 0.78
Body hair scores and total hair diameters in healthy women in the Kirikkale Region of Turkey. Yonsei Med J (2004) 0.78
Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity. Hum Fertil (Camb) (2011) 0.78
Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome. Gynecol Endocrinol (2012) 0.77
Race, rather than skin pigmentation, predicts facial hair growth in women. J Clin Aesthet Dermatol (2014) 0.77
[Clinical assessment of body hair growth in Japanese women. The relationship between a grade of hirsutism and the menstrual status]. Nihon Sanka Fujinka Gakkai Zasshi (1988) 0.76
Semiquantitative assessment of hirsutism in 850 PCOS patients and 2,988 controls in China. Endokrynol Pol (2014) 0.76
Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women. Clin Endocrinol (Oxf) (2015) 0.76
Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. J Biomed Res (2016) 0.75